iTeos Therapeutics, Inc. (ITOS): Operatsion rentabellik

Ommaviy kompaniya iTeos Therapeutics Inc (ITOS) logotipi

iTeos Therapeutics saratonni davolashning innovatsion usullarini ishlab chiqmoqda, bu esa kelajakdagi daromadlar o'sishi uchun asos yaratmoqda. Operatsion foyda marjasi ushbu strategiyaning barqarorligini tasdiqlaydi, bunda ko'rsatkich 0.00 darajasida saqlanmoqda. GSK bilan hamkorlikda antitelolarning global rivojlanishi bozor ulushini egallashni ta'minlaydi, qat'iy nazorat ostidagi uchinchi tomon pudratchilariga testlarni autsorsing qilish esa operatsion xatarlarni minimallashtiradi.

iTeos Therapeutics Inc (ITOS): Operatsion faoliyat rentabelligi 04.07.2022dan 14.09.2025gacha

iTeos Therapeutics (ITOS) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning fundamental baholanishi:iteostherapeutics.com, ITOS
iTeos Pharma brendining mahsuloti

Operatsion marja daromadni soliqlar va foizlardan oldingi foydaga aylantirish samaradorligini o'lchaydi va biznesning o'z asosiy faoliyatidan pul oqimini yaratish qobiliyatini aks ettiradi. Operatsion daromad koeffitsiyentini tahlil qilish orqali investor iTeos Therapeutics (ITOS) kompaniyasining R&D asosiy xarajatlari va aksiyalar opsion dasturlari orqali nufuzli onkologlarni saqlab qolish choralari yakuniy rentabellikka hamda kompaniyaning fundamental qiymatiga qanday ta'sir qilishini ko'rishi mumkin.

iTeos Therapeutics raqobatchilari

ARGX (argenx N.V.) - Operatsion marja|Sotuvning operatsion rentabelligi BioNTech Pharma BNTX|Sotuvning operatsion marjasi ABVX (ABIVAX)|Operatsion marja ADMA Biologics, Inc. (ADMA)|Operatsion marja PTGX (protagonist-inc.com)|IMVT: Operatsion foyda bo'yicha sotuv rentabelligi|KNSA - Operatsion rentabellik|GRFS: Operatsion rentabellik|ADPT (Adaptive Biotechnologies) - Sotuvning operatsion marjasi|Operatsion foyda bo'yicha sotuv rentabelligi CLDX|Sotuvning operatsion marjasi AUPH|BCRX (BioCryst Pharmaceuticals) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Vera Pharma (VERA)|DNTH (Dianthus Therapeutics) - Operatsion foyda normasi|Pharvaris N.V. - Sotuvning operatsion marjasi|Operatsion foyda normasi ABCL|TRML: Sotuvning operatsion marjasi|PGEN (Precigen) - Operatsion foyda bo'yicha sotuv rentabelligi|pharming.com (PHAR) - Operatsion rentabellik|Nektar Corp (NKTR) - Operatsion marja|UPB (upstreambio.com) - Operatsion marja|ZBIO: Operatsion foyda normasi|Operatsion marja IMNM|Operatsion faoliyat rentabelligi Gossamer Bio Inc|Operatsion marja KALV (KalVista Pharma)|SEPN (Septerna Pharma) - Operatsion foyda marjasi|PVLA: Sotuvning operatsion marjasi|Operatsion foyda marjasi SVRA|RIGL: Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi ANAB|ATXS (Astria Corp) - Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi ENGN (enGene Bio)|Operatsion marja RAPT|Operatsion faoliyat rentabelligi Aerovate Therapeutics|Operatsion rentabellik Aclaris Therapeutics Inc. ACRS|Operatsion faoliyat rentabelligi Kyverna Therapeutics Inc. (KYTX)|TLSA - Operatsion rentabellik|CABA: Operatsion rentabellik|VTYX (Ventyx Biosciences, Inc.) - Sotuvning operatsion marjasi|THTX - Operatsion faoliyat rentabelligi|AVTX (avalotx.com) - Operatsion marja|Sotuvning operatsion rentabelligi Eledon Pharmaceuticals Inc. ELDN|Operatsion marja AGEN|CLYM (Climb Bio, Inc.) - Operatsion foyda normasi|Operatsion rentabellik zurabio.com ZURA|ATYR - Sotuvning operatsion marjasi|Adagene Inc - Operatsion marja|ImageneBio (IMA) - Sotuvning operatsion marjasi|Shattuck Therapeutics (STTK) - Operatsion rentabellik|Sotuvning operatsion rentabelligi Equillium Inc (EQ)|Sotuvning operatsion marjasi CNTB|Operatsion foyda bo'yicha sotuv rentabelligi IMUX (Immunic, Inc.)|Operatsion rentabellik Atara Biotherapeutics, Inc. (ATRA)|IFRX - Sotuvning operatsion rentabelligi|Operatsion faoliyat rentabelligi XFOR|Operatsion faoliyat rentabelligi Adicet (ACET)|CELU - Operatsion rentabellik|INMB (INmune Bio, Inc.) - Operatsion foyda bo'yicha sotuv rentabelligi|BRNS: Operatsion marja|Kezar Life Sciences Inc. (KZR) - Operatsion marja|Operatsion rentabellik SAB Biotherapeutics Inc|Operatsion marja Akari Therapeutics, Plc|Operatsion rentabellik Enlivex Therapeutics Ltd (ENLV)|QTTB - Sotuvning operatsion rentabelligi|Operatsion marja GOVX (GeoVax Corp)|Edesa Biotech (EDSA) - Sotuvning operatsion rentabelligi|iBio Corporation - Operatsion marja|CARM (carismatx.com) - Operatsion foyda bo'yicha sotuv rentabelligi|XTLB (XTL Bio) - Sotuvning operatsion marjasi|Sotuvning operatsion rentabelligi Bolt Biotherapeutics Inc. (BOLT)|Sotuvning operatsion marjasi HCWB|Aptevo Therapeutics Inc. - Operatsion foyda marjasi|Operatsion rentabellik AIM ImmunoTech, Inc. (AIM)|Operatsion marja Aditxt Corp (ADTX)|Operatsion marja GRI (GRI Bio Corporation)|XORTX Therapeutics (XRTX) - Sotuvning operatsion rentabelligi|HIND: Sotuvning operatsion marjasi|Sotuvning operatsion rentabelligi Revelation Bio|INDP: Operatsion marja|Sotuvning operatsion rentabelligi BiondVax Pharmaceuticals (SCNI)|CALI (calcimedica.com) - Operatsion marja|affimed.com (AFMD) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Allakos (ALLK)|HOOK (HOOKIPA Pharma, Inc.) - Operatsion foyda normasi|Operatsion rentabellik igmbio.com IGMS|Ocean Bio - Operatsion rentabellik|TC BioPharm Ltd - Operatsion marja|Sotuvning operatsion rentabelligi thirdharmonicbio.com